← P3 Health Partners Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($42.0m) | ($31.4m) | ($146.4m) | ($1.6b) | ($186.4m) | ($310.4m) | ($323.1m) | — | |
| Depreciation and amortization | — | — | $1.6m | $87.3m | $86.7m | $86.1m | $84.2m | $84.2m | |
| Amortization of original issue discount and debt issuance costs | — | — | $1.8m | $0 | $472k | $87k | $13.6m | — | |
| Deferred income taxes | — | — | — | — | $0 | ($1.1m) | $2.9m | $3.3m | |
| Impairment of assets held for sale | — | — | — | — | $0 | $8.1m | $0 | — | |
| Accounts payable, accrued expenses, and other current liabilities | — | — | $34.2m | $6.1m | $16.0m | ($8.1m) | $11.1m | $9.9m | |
| Increase in accounts payable related to private placement offering costs | — | — | — | $0 | $12k | $686k | $0 | — | |
| Increase in accounts payable related to at-the-market offering costs | — | — | — | $0 | $19k | $0 | — | — | |
| Accrued payroll | $503k | $2.3m | ($1.1m) | $1.9m | $282k | ($784k) | ($772k) | — | |
| Accrued interest | $2.2m | $1.8m | $5.2m | $5.3m | $9.6m | $7.9m | ($1.9m) | — | |
| Increase in accrued expenses related to debt issuance costs and original issue discount | — | — | — | $525k | $212k | $307k | $0 | — | |
| Increase in accrued expenses related to at-the-market offering costs | — | — | — | $0 | $206k | $0 | — | — | |
| Prepaid expenses and other current assets | — | — | $4.3m | $4.3m | ($1.2m) | ($10.8m) | $3.0m | — | |
| Net cash used in operating activities | ($28.3m) |
($24.6m)
+13.05%
|
($51.1m)
-107.88%
|
($126.0m)
-146.47%
|
($76.0m)
+39.67%
|
($110.1m)
-44.85%
|
($91.2m)
+17.15%
|
($85.2m)
+6.58%
|
|
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | — | — | — | — | $0 | ($13.3m) | $162k | ($4.7m) | |
| Purchases of property and equipment | $1.5m | $2.9m | ($3.3m) | ($2.2m) | ($1.8m) | $0 | $79k | ($119k) | |
| Net cash provided by investing activities | ($3.9m) | ($3.2m) | ($8.2m) | ($7.7m) | ($1.8m) | $14.5m | $129k | $86k | |
| Provision for bad debts | — | — | — | — | — | $0 | $3.0m | — | |
| Proceeds from long-term debt, net of original issue discount | $16.2m | $36.4m | $24.6m | $15.0m | $14.1m | $88.1m | $73.0m | — | |
| Payment of debt issuance costs | — | — | ($375k) | $0 | ($173k) | ($103k) | ($186k) | — | |
| Repayment of short-term and long-term debt | ($14.6m) | ($1.5m) | ($187k) | ($46k) | $0 | ($31.0m) | ($1.1m) | — | |
| Proceeds from short-term debt | — | — | $352k | — | $0 | $1.9m | $1.1m | — | |
| Warrants issued in connection with new debt | — | — | — | $643k | $0 | $12.1m | $26.7m | — | |
| Net cash provided by financing activities | $63.6m |
$34.8m
-45.36%
|
$24.8m
-28.68%
|
$11.4m
-54.12%
|
$100.3m
+782.04%
|
$98.8m
-1.56%
|
$72.8m
-26.28%
|
$70.0m
-3.92%
|
|
| Cash and restricted cash, beginning of year | $32.9m | $39.9m | $5.4m | $18.5m | $40.9m | $44.1m | $25.8m | — | |
| Net change in cash and restricted cash | $31.5m | $7.0m | ($34.5m) | ($122.4m) | $22.5m | $3.2m | ($18.3m) | — | |
| Restricted cash | — | — | $54k | $920k | $4.6m | $5.3m | $795k | — | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Equity-based compensation | $474k | $447k | $3.7m | $19.4m | $6.0m | $5.8m | $5.6m | — | |
| Paid in-kind interest expense | $560k | $685k | $2.8m | $5.7m | $5.8m | $7.9m | $29.7m | — | |
| Accretion of contingent consideration | — | — | — | $400k | $113k | $0 | — | — | |
| Gain on write off of contingent consideration | — | — | — | — | $0 | ($4.9m) | $0 | — | |
| Mark-to-market adjustment of stock warrants | — | — | $7.7m | ($9.9m) | ($433k) | ($22.1m) | ($7.8m) | — | |
| Premium deficiency reserve | $6.4m | ($20.5m) | $11.6m | ($11.5m) | ($12.7m) | $53.7m | $18.7m | — | |
| Health plan receivable | ($9.7m) | ($27.5m) | ($2.8m) | ($21.8m) | ($46.6m) | ($2.8m) | $28.7m | — | |
| Clinic fees, insurance, and other receivable | — | — | ($1.5m) | ($5.3m) | $4.6m | ($990k) | ($2.3m) | — | |
| Other long-term assets | — | — | — | $100k | ($58k) | ($43k) | ($3.5m) | — | |
| Health plan settlements payable | $1.9m | $8.8m | $11.3m | ($8.9m) | $21.4m | $20.6m | $14.3m | — | |
| Claims payable | $12.1m | $37.1m | $19.1m | $49.2m | $26.8m | $77.1m | $32.7m | — | |
| Operating lease liability | — | — | $306k | $4.0m | ($450k) | $53k | $641k | — | |
| Other long-term liabilities | — | — | — | — | $0 | $5.9m | $0 | — | |
| Proceeds from asset sale | — | — | — | — | — | $14.5m | $50k | — | |
| Proceeds from liability-classified warrants and private placement offering, net of offering costs paid | — | — | — | $0 | $86.6m | $40.5m | $0 | — | |
| Proceeds from at-the-market sales, net of offering costs paid | — | — | — | — | $0 | $33k | $0 | — | |
| Deferred offering costs paid | — | — | — | $0 | ($175k) | ($507k) | $0 | — | |
| Payment of tax withholdings upon settlement of restricted stock unit awards | — | — | — | $0 | ($16k) | ($103k) | $0 | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activity | $560k | $685k | $2.8m | $5.7m | $5.8m | $14.2m | $13.6m | — | |
| Income Taxes Paid | — | — | — | $0 | $567k | $5.5m | $1.4m | — | |
| Operating lease liabilities arising from obtaining new right-of-use assets | — | — | $4.1m | $6.8m | $7.2m | $617k | $361k | — | |
| Operating Lease Right Of Use Assets Reduced Due To Lease Modification And Termination | — | — | — | — | $0 | ($92k) | $0 | — | |
| Increase in other receivable related to at-the-market sales proceeds | — | — | — | $0 | $33k | $0 | — | — | |
| Restricted stock unit awards issued in satisfaction of executive transaction bonuses | — | — | — | $0 | $5.0m | $0 | — | — | |
| Remeasurement adjustment to redeemable noncontrolling interest resulting from ownership changes | — | — | — | $0 | ($117.9m) | ($22.8m) | ($3.9m) | — | |
| Fair value adjustment to redeemable noncontrolling interest | — | — | — | $0 | $20.6m | ($20.6m) | $119.4m | — | |
| Cash | — | — | $5.3m | $17.5m | $36.3m | $38.8m | $25.0m | ($85.2m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.